| Bio Roundup: A Royal IPO, Akili Arrives, Orca Bio Surfaces & More | Frank Vinluan | 06/19/20 | National |
| AskBio Reels In $235M to Advance Gene Therapy Clinical Trials | Frank Vinluan | 04/11/19 | Raleigh Durham |
| Roche Bets $4.8B on Spark Therapeutics and the Future of Gene Therapy | Ben Fidler | 02/25/19 | National |
| Bio Roundup: CRISPR Ruling, “America’s Nobels,” IPOs & More | Frank Vinluan | 09/14/18 | National |
| FDA, Following EMA, Nixes Amicus’ Plans for Speedy OK of Pompe Drug | Ben Fidler | 09/10/18 | New York |
| Bio Roundup: Lung Cancer Questions, Migraine Races, HIV Battle & More | Ben Fidler | 02/09/18 | National |
| Pompe Disease Patients on Amicus Drug Continue to Improve in Study | Frank Vinluan | 02/07/18 | New York |
| Avrobio Raises $60M for Fabry Disease Gene Therapy, Rest of Pipeline | Frank Vinluan | 02/01/18 | Boston |
| Bio Roundup: Nobel Pursuit, Fundraising Fruit, A Rhythmic IPO & More | Alex Lash | 10/06/17 | National |
| Amicus Therapeutics’ Pompe Drug Data Show Improved Muscle Movement | Frank Vinluan | 10/04/17 | New York |
| Audentes Prices $75M IPO As Gene Therapy Eyes First U.S. Approval | Ben Fidler | 07/20/16 | San Francisco |
| Amicus Wheels, Deals, Restructures Following Fabry Drug Setback | Ben Fidler | 11/20/13 | New York |
| Amicus, Biogen Team Up on Parkinson’s Drug Deal | Ben Fidler | 09/10/13 | Boston |
| Audentes, Loaded With $30M, Pursues Gene Therapy for Rare Diseases | Luke Timmerman | 07/26/13 | San Francisco |
| Henri Termeer on Startups, Drug Prices, Getting Older (Part 2) | Luke Timmerman | 05/14/13 | National |
| Amicus Counts on “Chaperone” Tech to Enhance Rare Disease Treatments | Arlene Weintraub | 01/11/12 | New York |
| BioMarin Buys ZyStor For $115M | Luke Timmerman | 08/18/10 | San Francisco |
| FDA Approves Genzyme Pompe Drug, Vertex Hepatitis C Drug Trial Succeeds, Thermo Fisher Acquires Fermentas, & More Boston-Area Life Sciences News | Erin Kutz | 05/28/10 | Boston |
| Genzyme Gets FDA Nod for Pompe Drug | Ryan McBride | 05/25/10 | Boston |
| FDA to Rule on Genzyme Drug in Six Months | Ryan McBride | 01/21/10 | Boston |
| FDA Shoots Down Genzyme’s Latest Bid for Pompe Drug Approval | Ryan McBride | 11/16/09 | Boston |
| Genzyme Fails to Win FDA Approval for Large-Scale Production of Pompe Drug | Luke Timmerman | 03/02/09 | Boston |
| Genzyme Nabs Two Key Regulatory Approvals, Expected to Trigger Revenue Growth | Ryan McBride | 02/26/09 | Boston |
| FDA Plans To Clear Genzyme’s Myozyme Made at Large Scale | Luke Timmerman | 11/17/08 | Boston |
| FDA Panel Favors Genzyme’s Myozyme | Ryan McBride | 10/22/08 | Boston |
| Genzyme Expects FDA Review of Myozyme Factory by Thanksgiving Weekend | Luke Timmerman | 09/23/08 | Boston |
